Concepedia

AML-484 First Results of a Phase II Study (STIMULUS-AML1) Investigating Sabatolimab + Azacitidine + Venetoclax in Patients With Newly Diagnosed Acute Myeloid Leukemia (ND AML)

Amer M. Zeidan, Jörg Westermann, Tibor Kovacsovics, Sarit Assouline, Andre C. Schuh, Hee‐Je Kim, Gabriela Rodríguez Macias, David Sanford, Marlise R. Luskin, Eytan M. Stein,

Clinical Lymphoma Myeloma & Leukemia · 2022 · 17 citations · 0 references

Concepts

MedicinePharmacologyPharmacotherapyChemotherapyHematologic OncologyMedical OncologyChemotherapy In Hematologic MalignanciesHematologic Malignancy PharmacotherapyHematologic Malignancy TherapyAcute Leukemia ChemotherapyAcute LeukemiasAcute Myeloid Leukemia TherapyAcute Myeloid Leukemia TreatmentPhase Ii InvestigationStudy Phase